Published in JPEN J Parenter Enteral Nutr on March 15, 1990
Postoperative feeding. BMJ (1991) 1.82
Parenteral nutrition: Revisited. Indian J Anaesth (2010) 0.98
Nutritional support in critically ill patients. Ann Surg (1994) 0.83
Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences. Nutr Clin Pract (2016) 0.77
Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition. Gut (1998) 0.77
Significantly decreased: clinically impaired? JPEN J Parenter Enteral Nutr (1991) 0.75
The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD). Nutrients (2012) 0.75
Updates in Nutrition Support for Critically Ill Adult Patients. Hosp Pharm (2017) 0.75
Evolution of liver transplantation. Hepatology (1982) 19.54
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Stress-induced hyperglycemia. Crit Care Clin (2001) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Prevalence of malnutrition in general medical patients. JAMA (1976) 2.95
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80
Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr (1998) 2.74
Protein status of general surgical patients. JAMA (1974) 2.66
Growth-stimulating factor in regenerating canine liver. Lancet (1979) 2.61
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Detection of circulating immune complexes in pathological human sera. Lancet (1975) 2.51
Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49
Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg (1978) 2.48
Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr (1977) 2.36
The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35
Postoperative fluid overload: not a benign problem. Crit Care Med (1990) 2.35
Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med (2013) 2.22
Human cadaveric renal transplantation. Report of twenty cases. Br Med J (1965) 2.12
Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months. J Am Coll Cardiol (1999) 2.09
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet (1989) 2.01
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91
Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet (1993) 1.84
Progress in homotransplantation of the liver. Adv Surg (1966) 1.83
Fungus infections after liver transplantation. Ann Surg (1977) 1.81
Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80
Hypocaloric total parenteral nutrition: effectiveness in prevention of hyperglycemia and infectious complications--a randomized clinical trial. Crit Care Med (2000) 1.79
Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am (1995) 1.79
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
The quality of life after liver transplantation. Transplant Proc (1979) 1.78
Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med (2001) 1.78
Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78
Prognostic factors in sterile pancreatic necrosis. Gastroenterology (1992) 1.77
Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet (1975) 1.74
Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72
Homotransplantation of the liver. Transplantation (1967) 1.71
Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology (1994) 1.70
Human renal transplants. II. Immunofluorescent and immunoferritin studies. Lab Invest (1968) 1.69
Reduced activity of the red-cell sodium-potassium pump in human obesity. N Engl J Med (1980) 1.68
Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66
Portacaval shunt in hyperlipoproteinaemia. Lancet (1973) 1.66
Responsible and irresponsible use of very-low-calorie diets in the treatment of obesity. JAMA (1990) 1.65
Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J Clin Oncol (1993) 1.64
The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63
Obesity prevalence by age group and 5-year changes in adults residing in rural Wisconsin. J Am Diet Assoc (2000) 1.57
Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet (1975) 1.55
The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54
Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site. Transplantation (1977) 1.54
Liver replacement for alpha1-antitrypsin deficiency. Surgery (1977) 1.53
Evaluation of a practical technique for determining insulin requirements in diabetic patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr (1993) 1.52
Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest (1989) 1.52
Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation (1988) 1.52
Liver replacement for pediatric patients. Pediatrics (1979) 1.51
Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet (1969) 1.51
Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50
Sibutramine produces dose-related weight loss. Obes Res (1999) 1.50
Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr (1999) 1.50
Protein dynamics during refeeding of protein-depleted rats: effects of increasing amino acid intake by TPN or enteral continuous feeding. J Nutr (1984) 1.50
Symptomatic hyperlipasemia after cardiopulmonary bypass: implications for enteral nutritional support. Nutrition (1993) 1.48
Albumin supplementation in the critically ill. A prospective, randomized trial. Arch Surg (1990) 1.47
Obesity and its comorbid conditions. Clin Cornerstone (1999) 1.46
The human metabolic response to chronic ketosis without caloric restriction: preservation of submaximal exercise capability with reduced carbohydrate oxidation. Metabolism (1983) 1.45
Protein sparing therapy during periods of starvation with sepsis of trauma. Ann Surg (1973) 1.45
Factors determining peripheral vein tolerance to amino acid infusions. Arch Surg (1979) 1.45